Literature DB >> 28545889

CAR: A key regulator of adhesion and inflammation.

Elena Ortiz-Zapater1, George Santis2, Maddy Parsons3.   

Abstract

The coxsackie and adenovirus receptor (CAR) is a transmembrane receptor that plays a key role in controlling adhesion between adjacent epithelial cells. CAR is highly expressed in epithelial cells and was originally identified as a primary receptor for adenovirus cell binding. However, studies over the last 10 years have demonstrated that CAR plays a key role in co-ordinating cell-cell adhesion under homeostatic conditions including neuronal and cardiac development and cell junction stability; it has also been implicated in pathological states such as cancer growth and leukocyte transmigration during inflammation. Here we provide an overview of the functions of CAR as an adhesion molecule and highlight the emerging important role for CAR in controlling both recruitment of immune cells and in tumorigenesis.
Copyright © 2017 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cancer; Cell-cell adhesion; Coxsackievirus adenovirus receptor; Inflammation; Transmigration

Mesh:

Substances:

Year:  2017        PMID: 28545889     DOI: 10.1016/j.biocel.2017.05.025

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  12 in total

Review 1.  Coxsackievirus B3-Its Potential as an Oncolytic Virus.

Authors:  Anja Geisler; Ahmet Hazini; Lisanne Heimann; Jens Kurreck; Henry Fechner
Journal:  Viruses       Date:  2021-04-21       Impact factor: 5.048

2.  Protective Role of Coxsackie-Adenovirus Receptor in the Pathogenesis of Inflammatory Bowel Diseases.

Authors:  Xiong Chen; Rui Liu; Xiaoming Liu; Canxia Xu; Xiaoyan Wang
Journal:  Biomed Res Int       Date:  2018-08-09       Impact factor: 3.411

3.  Coxsackievirus B3 Infection of Human iPSC Lines and Derived Primary Germ-Layer Cells Regarding Receptor Expression.

Authors:  Janik Böhnke; Sandra Pinkert; Maria Schmidt; Hans Binder; Nicole Christin Bilz; Matthias Jung; Uta Reibetanz; Antje Beling; Dan Rujescu; Claudia Claus
Journal:  Int J Mol Sci       Date:  2021-01-27       Impact factor: 5.923

4.  The Coxsackievirus and Adenovirus Receptor Has a Short Half-Life in Epithelial Cells.

Authors:  Poornima Kotha Lakshmi Narayan; James M Readler; Mahmoud S Alghamri; Trisha L Brockman; Ran Yan; Priyanka Sharma; Vladislav Snitsarev; Katherine J D A Excoffon; Abimbola O Kolawole
Journal:  Pathogens       Date:  2022-01-27

5.  CAR Co-Operates With Integrins to Promote Lung Cancer Cell Adhesion and Invasion.

Authors:  Claudia Owczarek; Elena Ortiz-Zapater; Jana Kim; Efthymia Papaevangelou; George Santis; Maddy Parsons
Journal:  Front Oncol       Date:  2022-02-14       Impact factor: 5.738

6.  Identification of key genes in the tumor microenvironment of lung adenocarcinoma.

Authors:  Wenxing Long; Qing Li; Jianfang Zhang; Hui Xie
Journal:  Med Oncol       Date:  2021-06-12       Impact factor: 3.064

Review 7.  Consequences of epigenetic derepression in facioscapulohumeral muscular dystrophy.

Authors:  Anna Greco; Remko Goossens; Baziel van Engelen; Silvère M van der Maarel
Journal:  Clin Genet       Date:  2020-03-04       Impact factor: 4.438

Review 8.  Human adenovirus binding to host cell receptors: a structural view.

Authors:  Aleksandra Cecylia Stasiak; Thilo Stehle
Journal:  Med Microbiol Immunol       Date:  2019-11-29       Impact factor: 3.402

9.  Induction of the Coxsackievirus and Adenovirus Receptor in Macrophages During the Formation of Atherosclerotic Plaques.

Authors:  Azadeh Nilchian; Estelle Plant; Malgorzata M Parniewska; Ana Santiago; Aránzazu Rossignoli; Josefin Skogsberg; Ulf Hedin; Ljubica Matic; Jonas Fuxe
Journal:  J Infect Dis       Date:  2020-11-13       Impact factor: 5.226

10.  JAML promotes CD8 and γδ T cell antitumor immunity and is a novel target for cancer immunotherapy.

Authors:  Joseph M McGraw; Flavian Thelen; Eric N Hampton; Nelson E Bruno; Travis S Young; Wendy L Havran; Deborah A Witherden
Journal:  J Exp Med       Date:  2021-08-24       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.